Announced Wed, 16 Apr · 18:50 IST

Analysts/Institutional Investor Meet/Con. Call Updates

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Remedium Lifecare Ltd (scrip code 539561 / REMLIFE) has informed BSE about a virtual investors meet scheduled for April 21, 2025, at 4:30 PM. The discussion will center on the closing of the company's ongoing Rights Issue. The meeting will be held via Zoom and will not involve any unpublished price sensitive information (UPSI). This filing is a routine SEBI disclosure made under Regulation 30 of the LODR Regulations, 2015.

Likely market impact

Routine compliance disclosure with limited stock price impact, as no UPSI will be discussed. Shareholders get a chance to clarify doubts about the Rights Issue closure, but nothing materially new is being shared with the market.